Piper Sandler Maintains Overweight on Exact Sciences, Lowers Price Target to $80
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Westenberg maintains an Overweight rating on Exact Sciences (NASDAQ:EXAS) but lowers the price target from $90 to $80.
October 16, 2023 | 5:24 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Piper Sandler has maintained an Overweight rating on Exact Sciences but lowered the price target from $90 to $80.
The news is directly about Exact Sciences. Piper Sandler's decision to maintain an Overweight rating indicates a positive outlook for the company. However, the lowering of the price target may create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100